Govt Job for MBBS, MD, PG or equivalent in ESIC

Employee’s State Insurance Corporation Limited released Latest Govt Jobs recruitment of 59 vacancies for Senior Resident & Other Posts.

Here is a new update from ESIC RecruitmentEmployee’s State Insurance Corporation Limited, Delhi released plenty of jobs for the people looking for post graduate govt jobs.

The vacancies are available for Senior Resident Posts. The total number of vacancies available for ESIC Recruitment is 59.

Indian Government released 59 vacancies for ESIC Recruitment for Senior Resident Posts. This is good news for the candidates looking for post graduate govt jobs. ESIC Recruitment Notification is released on 8th July 2021.

The applicants applying for the latest govt jobs must read the ESIC Recruitment notification before applying. Candidates should have passed MD, PG Degree, DNB, MBBS or equivalent from a recognized university for applying to these posts of Senior Resident.

Age Limit for these various Senior Resident posts is 35 years. Eligible and Interested Candidates can apply on or before 15th July 2021.

Name of the Post:

  • Senior Resident
  • Specialist
  • Super Specialist

No. of Vacancies: 59

Job Location: New Delhi

Pay Scale: Rs. 1,01,000/- PM

Eligibility Criteria: Applicants should have passed MBBS, MD, DNB or equivalent from a recognized university for ESIC Recruitment 2021.

Age Limit:

  • Maximum Age Limit: 35

Selection Process:

  • Written Test
  • Interview

Application Fee: There is no application fee

How to Apply:

  • Eligible and interested applicants can apply online at the official website page at https://www.esic.nic.in/ ESIC Recruitment 2021.

Important Dates:

  • Starting Date for Submission of Application: 08/07/2021
  • Last date for Submission of Application: 15/07/2021

Important Links: https://www.esic.nic.in/

Related Posts

  • Pharma
  • July 10, 2025
  • 98 views
Pills & Profits: Can India’s pharma sector handle Trump’s planned 200% tariff dose?

India stands tall as a pharmaceutical powerhouse, supplying 20% of the world’s generic medicines and nearly 62% of global vaccines. Yet, this success now faces a storm: US President Donald…

  • Pharma
  • July 10, 2025
  • 93 views
Novartis wins approval for first malaria drug for newborns and babies

ZURICH: Novartis (NOVN.S), opens new tab said on Tuesday it had received approval in Switzerland for Coartem Baby, which it said was the first drug to treat malaria in babies…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Very Arty Surgery for Weight Loss by SSI Mantra, World’s First

Very Arty Surgery for Weight Loss by SSI Mantra, World’s First

Pills & Profits: Can India’s pharma sector handle Trump’s planned 200% tariff dose?

Pills & Profits: Can India’s pharma sector handle Trump’s planned 200% tariff dose?

Novartis wins approval for first malaria drug for newborns and babies

Novartis wins approval for first malaria drug for newborns and babies

Nectar to sell API, formulations & menthol biz to Ceph Lifesciences for Rs 1,290 cr

Nectar to sell API, formulations & menthol biz to Ceph Lifesciences for Rs 1,290 cr